ClearPoint Neuro, Inc. CLPT
| Déclarant | Citoyenneté ou lieu d'organisation | Pouvoir de vote unique | Pouvoir de vote partagé | Pouvoir de disposition unique | Pouvoir de disposition partagé | Montant en propriété effective | Pourcentage détenu | Date d'achat |
|---|---|---|---|---|---|---|---|---|
| The Vanguard Group - 23-1945930 | Pennsylvania | 0 | 35630 | 1265796 | 0 | 1308694 | 5.32 % | 13/02/2024 |
| (1) BlackRock, Inc. | Delaware | 1463364 | 0 | 1470056 | 0 | 1470056 | 6 % | 29/01/2024 |
| Bigger Capital Fund, LP | Delaware | 0 | 575484 | 0 | 575484 | 575484 | 2.8 % | 09/06/2021 |
| PTC Therapeutics, Inc. | Delaware | 2961245 | 0 | 2961245 | 10 | 2961245 | 14 % | 02/03/2021 |
| Thomas A. Satterfield, Jr. | 65000 | 655000 | 65000 | 655000 | 720000 | 4 % | 11/02/2021 | |
| Thomas A. Satterfield, Jr. | United States America | 110000 | 1115000 | 110000 | 0 | 1225000 | 7.8 % | 13/02/2020 |
| PTC Therapeutics, Inc. | 2956990 | 0 | 2956990 | 11 | 2956990 | 17.27 % | 31/01/2020 | |
| PTC Therapeutics, Inc. | Delaware | 1290323 | 0 | 1290323 | 10 | 1290323 | 9.56 % | 24/05/2019 |
| E. Jeffrey Peierls(1) | United States | 85000 | 605000 | 0 | 605000 | 690000 | 9.99 % | 09/02/2018 |
| Mellon Group, LLC | Florida | 587601 | 0 | 587601 | 0 | 587601 | 5.6 % | 05/02/2018 |
| Page 1 of 5 | United States of America | 50000 | 550000 | 50000 | 550000 | 600000 | 5.8 % | 12/01/2018 |
| only). | Delaware | 506621 | 0 | 506621 | 0 | 506621 | 4.9 % | 04/10/2017 |
| only). | Delaware | 506621 | 0 | 506621 | 0 | 506621 | 4.9 % | 04/10/2017 |
| Page 1 of 5 | United States of America | 50000 | 536855 | 50000 | 536855 | 586855 | 5.7 % | 19/09/2017 |
| Sabby Healthcare Master Fund, Ltd. | New York | 562500 | 0 | 562500 | 0 | 756619 | 4.46 % | 11/07/2017 |
| 2. | Delaware | 800000 | 0 | 8000001 | 0 | 8000001 | 7.7 % | 08/06/2017 |
| 2. | Delaware | 800000 | 0 | 800000 | 0 | 800000 | 7.7 % | 08/06/2017 |